Glycerol-modified poly-ε-caprolactone nanoparticles for drug delivery application
AbstractPlease download the paper to view the abstract.
Al Khouri N, Roblot-Treupel L, Fessi H, Devissaguet JP, Puisieux F. Development of a new process for the manufacture of polyisobutylcyanoacrylate nanocapsules. Int J Pharm. 1986; 28:125-32.
Anderson JM, Shive MS. Biodegradation and biocompatibility of PLA and PLGA microspheres. Advanced Drug Deliver Rev. 1997; 28:5-24.
Francis M, Cristea M, Winnik FM. Polymeric micelles for oral drug delivery: Why and how. Pure Appl Chem. 2004; 76:1321-1335.
Gref R, Luck M, Quellec P, Marchand M, Dellacherie E. 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf B. 2000; 18:301-313.
Kataoka K, Harada A, Nagasaki Y. Block copolymer micelles for drug delivery: design,characterization and biological significance. Adv Drug Deliver Rev 2001; 47:113-131.
Kayser O, Lemke A, Hernandez-Trejo N. The impact of nanobiotechnology on the development of new drug delivery systems. Curr Pharm Biotechnol. 2005; 6:3-5.
Kissel T, Li Y, Unge F. ABA-triblock copolymers from biodegradable polyester A-blocks and hydrophilic poly(ethylene oxide) B-blocks as a candidate for in situ forming hydrogel delivery systems for proteins. Adv Drug Deliver Rev. 2002; 54:99-124.
Kobayashi, S.; Uyama, H.; Kimura, S. Enzymatic Polymerization. Chem Rev. 2001, 101(12):3793-3818.
Leroux JC, Allemann E, Da Jaeghere F, Doelker E, Gurny R. Biodegradable nanoparticles - from sustained release formulations to improved site specific drug delivery. J Control Release. 1996; 39:339-350.
Li VHK, Wood RW. Ocular drug delivery of progesterone using nanoparticles. J Microencapsul. 1986; 3:213-218.
Melgar ZK, Chakraborty S. Biocatalytic synthesis and characterization of glycerol-modified branched poly-ε-caprolactone [thesis]. [Philippines]: Ateneo de Manila University; 2009. 35 p.
Peppas LB. Recent advances on the use of biodegradable microparticles and nanoparticles in the controlled drug delivery. Int J Pharm. 1995; 116:1-9.
Sinha VR, Bansal K, Kaushik R, Kumria R, Trehan A. Poly-caprolactone microspheres and nanospheres:an overview. Int J Pharm. 2004; 278:1-23.
Soppimath K, Aminabhavi T, Kulkami A, Rudzinski W. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release. 2001; 70:1-20.
Sÿachl R, Uchman M, Mateˇjı´cˇek P, Procha´zka K, Sÿteˇpa´nek M. Preparation and characterization of self-assembled nanoparticles formed by poly(ethylene oxide)-block-poly(epsilon-caprolactone) copolymers with long poly(epsilon-caprolactone) blocks in aqueous solutions. Langmuir. 2007; 23:3395-3400.
Wolinsky JB, William R, Colson YL, Grinstaff MW. Poly(carbonate ester)s based on units of 6-hydroxyhexanoic acid and glycerol. Macromolecules. 2007; 40:7065-7068.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).